Tracker

ETF universe handoff

Opening ETF evidence benchSynchronizing prices, risk metrics, holdings coverage, and source lineage

Company context

Solventum Corporation

NYSE:SOLV

Medical/Nursing Services · benchmarked against Health Services inside the XLV constituent company universe.

Active tabFinancial reports

Current readMixed

Last close78.69

1M return+4.32%

Open symbol page Watchlist context

OverviewVerdict, thesis map, and valuation setup.FundamentalsDrivers, trajectory, and business quality.Financial reportsStatement tables, sorting, filtering, and acceleration.Ex-ante forecastTarget price, dividend yield, and total return by horizon.FactorsCompany factor exposure, rank, and universe context.Market viewMomentum, catalysts, charts, and symbol packet.AttributionLarge-move causes, residuals, and research backlog.OwnershipSEC 13F holder flow, crowding, and manager changes.PeersPeer heatmap and closest comparables.

Tab scope

Raw financial statements

Financial reports

Source and lookbackStored financial report rows12 report snapshots; latest report May 11, 1:17 AM GMT+8.

Sample and caveat27 reported metrics across 4 sections.Use this tab for its stated job; heavier model packets stay on their own tabs.

Traditional statement tables

Financial reports

12 reports · latest May 11, 1:17 AM GMT+8

Distinct report rows12

Sections4

Metrics shown27of 28 tracked

Coverage96%

CompanySolventum Corporation

Overview scoring

Fundamental overview

41/100 blended · 97/100 confidence · benchmark Closest peers

Blended fundamental score: Earnings 40/100; Cash flow 35/100; Balance sheet 44/100; Valuation 51/100.

Broad comparison

Cohort scorecard

Coverage-adjusted score with thinner cohorts automatically down-weighted

Cohort scorecard: Closest peers 40/100; Medical/Nursing Services 55/100; Health Services 41/100; XLV constituent company universe 43/100.

Selected company rank

Rank and percentile

Confidence-adjusted standing inside each cohort

Rank and percentile: Closest peers #13 of 13; Medical/Nursing Services #3 of 3; Health Services #11 of 11; XLV constituent company universe #49 of 59.

Section scoring matrix

Earnings, cash flow, balance sheet, and valuation

Heatmap score by cohort and statement section

Section scoring matrix: Closest peers Earnings 40/100; Cash flow 34/100; Balance sheet 44/100; Valuation 44/100.

Sort byFilter metrics

Specialist report review

Quant, PM, and risk-manager reads

Deterministic review lanes from stored report metrics

Quant review

Favorable acceleration12/23

FCF yield has the largest second-order move at +2,403.12%. 12 metrics are accelerating favorably and 11 are decelerating.

Fundamental PM review

Growth and cash quality2/5

EPS TTM is 8.16 with -8.00% latest change. The PM lane checks revenue, EPS, cash flow, and margin confirmation together.

Risk manager review

Risk controls need review3 watch items

Debt / Equity is 1.06 with +2.38% latest change. The risk lane checks leverage, liquidity, and cash-yield deterioration.

Indexed report history

Financial report trend chart

First visible report = 100

Financial report trend chart: Total revenue 8.3B; Revenue quarter 2B; Operating income TTM 986M; Operating margin +11.84%.

Second order change

Acceleration chart

Favorable acceleration means the latest move improved versus the prior move

Acceleration chart: Total revenue +0.64%; Revenue quarter +5.13%; Operating income TTM -6.51%; Operating margin -7.18%.

PM / risk lens

Risk and quality radar

Directional score from change and acceleration

Risk and quality radar: Growth 45/100; Cash 67/100; Quality 26/100; Balance 40/100; Valuation 79/100.

Earnings

Metric trend table

10 of 10 metrics shown

Metric	Latest	Change	Acceleration	Trend	Samples
Total revenueRevenue	8.3B	-0.26%-22M	+0.64%+54M	stable	10
Revenue quarterRevenue	2B	+0.45%+9M	+5.13%+107M	accelerating	12
Revenue next quarterRevenue	2.2B	Need 2 reportsNeed 2 reports	Need 3 reportsNeed 3 reports	stable	1
Operating income TTMEarnings	986M	-5.74%-60M	-6.51%-68M	decelerating	10
Operating marginProfitability	+11.84%	-5.49%-0.69 pts	-7.18%-0.90 pts	decelerating	10
EPS TTMEarnings	8.16	-8.00%-0.71	-10.15%-0.90	decelerating	9
EPS next quarterEarnings	1.90	Need 2 reportsNeed 2 reports	Need 3 reportsNeed 3 reports	stable	1
Gross marginQuality	+56.60%	-0.05%-0.03 pts	+1.11%+0.64 pts	accelerating	10
Net marginQuality	+17.29%	-7.27%-1.36 pts	-10.37%-1.92 pts	decelerating	10
Gross-to-net conversionQuality	+30.54%	-7.22%-2.38 pts	-11.53%-3.74 pts	decelerating	10

Historical statement rows

Earnings report history

12 dated rows

Snapshot date	Total revenue	Revenue quarter	Revenue next quarter	Operating income TTM	Operating margin	EPS TTM	EPS next quarter	Gross margin	Net margin	Gross-to-net conversion
Jun 30, 2023	—	2.1B	—	—	—	—	—	—	—	—
Sep 30, 2023	—	2.1B	—	—	—	—	—	—	—	—
Dec 31, 2023	8.2B	2B	—	1.7B	+20.64%	7.79	—	+57.25%	+16.42%	+28.68%
Apr 1, 2024	8.2B	2B	—	1.7B	+20.82%	—	—	+57.64%	+15.73%	+27.28%
Jul 1, 2024	8.2B	2.1B	—	1.5B	+18.70%	6.12	—	+56.98%	+12.89%	+22.63%
Oct 7, 2024	8.2B	2.1B	—	1.3B	+15.90%	4.16	—	+56.38%	+8.76%	+15.54%
Jan 6, 2025	8.3B	2.1B	—	1.1B	+13.12%	2.76	—	+56.22%	+5.79%	+10.30%
Apr 7, 2025	8.3B	2.1B	—	886M	+10.67%	2.17	—	+55.45%	+4.55%	+8.21%
Jul 7, 2025	8.4B	2.2B	—	1.1B	+13.58%	2.17	—	+57.81%	+4.51%	+7.80%
Oct 6, 2025	8.4B	2.1B	—	1B	+12.32%	8.69	—	+57.30%	+18.08%	+31.56%
Jan 5, 2026	8.3B	2B	—	1B	+12.53%	8.87	—	+56.63%	+18.64%	+32.92%
May 11, 2026	8.3B	2B	2.2B	986M	+11.84%	8.16	1.90	+56.60%	+17.29%	+30.54%